| 2021 DORIS definition of remission in SLE: final recommendations from an international task force RF van Vollenhoven, G Bertsias, A Doria, D Isenberg, E Morand, MA Petri, ... Lupus science & medicine 8 (1), e000538, 2021 | 255 | 2021 |
| Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus MWP Tsang-A-Sjoe, IEM Bultink, M Heslinga, AE Voskuyl Rheumatology, kew377, 2016 | 157 | 2016 |
| Fc-gamma receptor polymorphisms differentially influence susceptibility to systemic lupus erythematosus and lupus nephritis MWP Tsang-A-Sjoe, SQ Nagelkerke, IEM Bultink, J Geissler, MWT Tanck, ... Rheumatology 55 (5), 939-948, 2016 | 72 | 2016 |
| Treatment targets in SLE: remission and low disease activity state V Golder, MWP Tsang-A-Sjoe Rheumatology 59 (Supplement_5), v19-v28, 2020 | 64 | 2020 |
| The relationship between remission and health-related quality of life in a cohort of SLE patients MWP Tsang-A-Sjoe, IEM Bultink, M Heslinga, LH van Tuyl, ... Rheumatology 58 (4), 628-635, 2019 | 42 | 2019 |
| B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid … S Bruijnen, M Tsang-A-Sjoe, H Raterman, T Ramwadhdoebe, D Vugts, ... Arthritis Research & Therapy 18, 1-8, 2016 | 40 | 2016 |
| Macrophages in lupus nephritis: exploring a potential new therapeutic avenue LE Kwant, Y Vegting, MWP Tsang-a-Sjoe, AJ Kwakernaak, L Vogt, ... Autoimmunity reviews 21 (12), 103211, 2022 | 32 | 2022 |
| New developments in systemic lupus erythematosus MWP Tsang-A-Sjoe, IEM Bultink Rheumatology 60 (Supplement_6), vi21-vi28, 2021 | 32 | 2021 |
| Anti-hinge antibodies recognize IgG subclass–and protease-restricted neoepitopes WJJ Falkenburg, D Van Schaardenburg, P Ooijevaar-de Heer, ... The Journal of Immunology 198 (1), 82-93, 2017 | 32 | 2017 |
| A multi-parameter response prediction model for rituximab in rheumatoid arthritis TD de Jong, J Sellam, R Agca, S Vosslamber, BI Witte, M Tsang-A-Sjoe, ... Joint Bone Spine 85 (2), 219-226, 2018 | 23 | 2018 |
| Systemic lupus erythematosus: review of synthetic drugs MWP Tsang-A-Sjoe, IEM Bultink Expert Opinion on Pharmacotherapy 16 (18), 2793-2806, 2015 | 22 | 2015 |
| Long-term evaluation of antimalarials in a Dutch SLE cohort: intolerance and other reasons for non-use MW Tsang-A-Sjoe, IE Bultink, AE Voskuyl Clin Exp Rheumatol 32 (1), 95-100, 2014 | 18 | 2014 |
| DORIS definition of remission in SLE: final recommendations from an international task force. Lupus Sci Med 8: e000538 RF Van Vollenhoven, G Bertsias, A Doria, D Isenberg, E Morand, MA Petri, ... | 16 | 2021 |
| Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity MWP Tsang-A-Sjoe, IEM Bultink, LA Korswagen, A van der Horst, ... Molecular Immunology 92, 125-131, 2017 | 12 | 2017 |
| Pharmacodynamic monitoring of (immuno) proteasome inhibition during bortezomib treatment of a critically ill patient with lupus nephritis and myocarditis KA de Groot, MT a Sjoe, D Niewerth, J Cloos, JL Blank, HWM Niessen, ... Lupus Science & Medicine 2 (1), e000121, 2015 | 11 | 2015 |
| Unexpected severe incident vertebral fractures in patients with systemic lupus erythematosus: comment on the article by Zhu et al. J Jacobs, MWP Tsang A Sjoe, AE Voskuyl, WF Lems, IEM Bultink Lupus 24 (2), 222-223, 2015 | 4 | 2015 |
| Intercurrent infection as a risk factor for disease flares in patients with systemic lupus erythematosus F El Hadiyen, MWP Tsang-A-Sjoe, BI Lissenberg-Witte, AE Voskuyl, ... Lupus Science & Medicine 11 (2), e001131, 2024 | 1 | 2024 |
| OP0144 SLE-T2T–A digital treat-to-target clinical decision support system for the management of systemic lupus erythematosus patients: development and usability evaluation AP Sanchez, MG Grimberg, MMA Hanssen, MO Aben, EE Jairth, ... Annals of the Rheumatic Diseases 81, 93, 2022 | 1 | 2022 |
| S2D: 5 Exosomes target renal tubular epithelial cells transferring inflammatory epstein–barr virus-encoded small rna (eber1) in lupus nephritis patients SR Baglio, N Masoumi, MW Tsang-a-Sjoe, MA van Eijndhoven, ... Lupus Science & Medicine 5 (Suppl 1), 2018 | 1 | 2018 |
| A novel and effective prediction model of response to rituximab in rheumatoid arthritis AM van Sijl, Tsang-A-Sjoe, Michel WP, HG Raterman, MT Nurmohamed, ... ARTHRITIS AND RHEUMATISM 65, S1016-S1016, 2013 | 1 | 2013 |
